Applied Evidence

Transitioning patients with developmental disabilities to adult care

Author and Disclosure Information

 

References

Mental and behavioral health problems can have a profound impact on the quality of life of patients with IDD, their peers, and their family and other caregivers. If untreated, these problems can lead to premature institutionalization, loss of employment or desired program participation, fractured social relationships, and caregiver withdrawal and burnout.

Initial evaluation of suspected mental and behavioral health problems begins with careful assessment for medical conditions that might be causing pain and distress, stereotypies, and other problematic behaviors. Common sources of pain and discomfort include dental and other oral disease, dysphagia, gastroesophageal reflux disease, gastritis, constipation, allergic disease, headache, musculoskeletal pathology, lower urinary tract disease, and gynecologic disorders.11 Identification and optimal treatment of medical conditions might not eliminate problematic behaviors but often decrease their frequency and intensity.

Psychoactive medications are prescribed for many patients with IDD. Many have behavioral adverse effects, such as akathisia, aggression, and disinhibition—leading to a prescribing cascade of psychoactive medication polypharmacy and escalating dosages.21 Antipsychotic medications are often initiated without a careful diagnosis, explicit outcome targets, or adequate clinical monitoring for effectiveness; in addition, they often lead to insulin resistance, metabolic syndrome, and massive weight gain.21 Even a family physician who is not the prescriber can perform an important advocacy role by critically reviewing psychoactive medications, documenting adverse effects, insisting on a clear therapeutic target, and calling for discontinuation of medications that appear to be ineffective.

Evaluation of mental and behavioral health problems requires a developmental perspective to interpret specific, observable behaviors with a proper clinical lens. For example, many patients with IDD engage in self-talk (soliloquizing) as a means of processing the world around them. This practice might escalate during a time of physical or psychological stress, and the unwary clinician might misinterpret this behavior as psychotic, leading to inappropriate prescribing of antipsychotic medication. Other psychotoform behaviors that, superficially, mimic but are typically not truly psychotic, include talk with or about imaginary friends and repetitive retelling of sometimes elaborate or grandiose tales or assertions. The failure of clinicians to recognize developmentally determined expressions of distress often leads to a misdiagnosis of schizophrenia or other psychotic illness and, consequently, inappropriate psychopharmacotherapy.

Family physicians, familiar with the use of psychiatric scales for diagnosis and treatment monitoring, should use similar scales that have been developed specifically for patients with IDD (TABLE 311). In addition, a psychiatric diagnosis manual, the Diagnostic Manual—Intellectual Disability 2, specific to people with IDD (and analogous to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) provides modification of diagnostic criteria to account for patients who have difficulty articulating their internal emotional state and inner thoughts.22

Screening and monitoring tools for co-occurring mental and behavioral health problems in patients with IDD

Continue to: Problematic behaviors

Pages

Recommended Reading

FDA rejects teplizumab for type 1 diabetes delay
MDedge Family Medicine
New drug, finerenone, approved for slowing kidney disease in diabetes
MDedge Family Medicine
South Asian ancestry associated with twice the risk of heart disease
MDedge Family Medicine
Not so crazy: Pancreas transplants in type 2 diabetes rising
MDedge Family Medicine
Rising rates of T1D in children: Is COVID to blame?
MDedge Family Medicine
New agents for youth-onset type 2 diabetes ‘finally in sight’
MDedge Family Medicine
Metformin use may curb BCC risk
MDedge Family Medicine
ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows
MDedge Family Medicine
Statin safety, low muscle pain risk upheld in ‘reassuring’ study
MDedge Family Medicine
Cycling linked to longer life in people with type 2 diabetes
MDedge Family Medicine